Strengths and weaknesses of a planar whole-body method of 153Sm dosimetry for patients with metastatic osteosarcoma and comparison with three-dimensional dosimetry

Authors

Donika Plyku, Johns Hopkins University
David M. Loeb, Johns Hopkins University
Andrew Prideaux, Johns Hopkins University
Sébastien Baechler, University of Lausanne
Richard L. Wahl, Washington University School of Medicine in St. Louis
George Sgouros, Johns Hopkins University
Robert F. Hobbs, Johns Hopkins University

Journal

Cancer Biotherapy and Radiopharmaceuticals

Publication Date

2015

Volume

30

Issue

9

Inclusive Pages

369-379

Document Type

Open Access Publication

Rights and Permissions

This is a copy of an article published in Cancer Biotherapy and Radiopharmaceuticals © 2015 © Mary Ann Liebert, Inc.; [JOURNAL TITLE] is available online at: http://online.liebertpub.com.

Recommended Citation

Plyku, Donika; Loeb, David M.; Prideaux, Andrew; Baechler, Sébastien; Wahl, Richard L.; Sgouros, George; and Hobbs, Robert F., "Strengths and weaknesses of a planar whole-body method of 153Sm dosimetry for patients with metastatic osteosarcoma and comparison with three-dimensional dosimetry." Cancer Biotherapy and Radiopharmaceuticals. 30, 9. 369-379. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/4407